Skip to main content

Table 2 Patient survey results

From: Patient experience with NER1006 as a bowel preparation for colonoscopy: a prospective, multicenter US survey

Topic and response categories Patients, n (%)
n = 1598
Dosing of NER1006
 2-day pm/am dosing regimen 1463 (91.6)
 1-day am/am dosing regimen (day of colonoscopy) 135 (8.4)
Volume of bowel preparation regimen completed
 All 1392 (87.1)
 Most 167 (10.5)
 At least half 29 (1.8)
 Less than half 10 (0.6)
“How easy was it for you to prepare and take [NER1006]?”
 Very easy (score, 7–9) 1216 (76.1)
 Medium level of difficulty (score, 4–6) 245 (15.3)
 Very difficult (score, 1–3) 137 (8.6)
“How important is it to you that [NER1006] can be taken with your choice of clear liquids?”
 Very important (score, 7–9) 1192 (74.6)
 Medium importance (score, 4–6) 273 (17.1)
 Not important (score, 1–3) 133 (8.3)
“Would you be willing to recommend [NER1006] to family/friends?”
 Yes 1027 (64.3)
 Maybe 414 (25.9)
 No 157 (9.8)
“How was your experience with [NER1006] compared to the other bowel cleansing medications(s) you previously used?a n = 1005
 Much better/better 656 (65.3)
 About the same 195 (19.4)
 Worse/much worse 154 (15.3)
  1. aFor the 1005 patients for whom this was not their first colonoscopy, prior bowel cleansing medications were: 4 L PEG (23.5%; any formulation), oral sodium sulfate (17.1%), over-the-counter agent(s) (12.8%), 2 L PEG (11.4%), other (13.0%), or unknown (39.4%). Patients may have selected > 1 prior bowel preparation. PEG: polyethylene glycol. Used with permission from Cash B. and Moncrief MBC, abstract 534. Am J Gastroenterol. 2019; 114:S36 [14]